The scholarly study is part of the Carotid Revascularization Endarterectomy vs. Stenting Trial . It had been presented in summary type at the International Stroke Conference in San Antonio, Texas, Feb. 26. Stroke, the third-leading cause of death in the country, is caused by an interruption in blood flow to the mind by a clot or bleeding. The carotid arteries on each relative side of the neck will be the major source of blood circulation to the brain.Topics explored in the publication include wellness and wellness, transportation, housing, long-term treatment, income, employment and retirement, and the needs of special populations . Aging in Rural Locations can be packaged with links to podcast interviews of specialists employed in the field, dialogue questions, PowerPoint slides, a check question bank, and recommended activities and exercises to help readers understand the materials.

APP’s lyophilized Oxaliplatin for Injection receives FDA advertising approval APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Keeping, Inc., announced today it received approval from the U.S.